Ongoing improvements in postoperative survival of glioblastoma in the temozolomide era: a population-based data linkage study

摘要

Translating outcomes achieved by clinical trials into routine care is crucial to improving outcomes of glioblastoma (GBM). This study examines the extent to which an advance in treatment for GBM has translated into meaningful, population-level survival benefits in New South Wales (NSW), Australia.